SGCE

Epsilon-sarcoglycan, transmembrane glycoprotein (~437 AA, ~43-50 kDa) that is component of sarcoglycan family within dystrophin-associated glycoprotein complex (DGC). Single-pass membrane protein with large N-terminal extracellular domain (heavily glycosylated, disulfide-bonded), transmembrane segment, and small cytoplasmic tail. Contains conserved N-linked glycosylation sites and cysteine residues. Maternally imprinted gene - maternal allele silenced, only paternal copy expressed in most tissues, resulting in autosomal-dominant inheritance with reduced penetrance (pathogenic variants usually cause disease only when inherited from father). Over 40 alternative transcript isoforms including brain-specific variants. In striated/cardiac muscle: component of sarcoglycan subcomplex within DGC at sarcolemma, forms physical link between intracellular cytoskeleton (via dystrophin) and extracellular matrix (via dystroglycan-laminin binding), stabilizing sarcolemma and protecting muscle fibers from contraction damage. ~60% sequence identity to α-sarcoglycan and can functionally substitute for it - overexpression in α-sarcoglycan-deficient mice rescues muscular dystrophy. In smooth muscle: replaces α-sarcoglycan as predominant isoform, partners with β-, δ-, ζ-sarcoglycan forming unique tetrameric assembly, maintaining same adhesive function linking muscle cortex to ECM. Loss of any sarcoglycan destabilizes entire complex causing mislocalization and degradation of remaining subunits. Primary molecular function is structural - integrates into DGC to maintain sarcolemmal integrity and resist mechanical stress (mechanoprotective role). In CNS: highly expressed in cerebral cortex, basal ganglia, hippocampus, cerebellum, olfactory bulb. Incorporated into DGC-like complexes in brain, co-assembling with β-, δ-, γ-, ζ-sarcoglycan and co-purifying with dystroglycans and dystrophin/utrophin. Predominantly neuronal expression (also perivascular astrocytes and brain blood vessels). Critical role in synaptic organization, particularly at inhibitory GABAergic synapses - functions as scaffold stabilizing synaptic proteins and neurotransmitter receptors. Localized in punctate pattern at synapses, co-distributed with GABA_A receptors in hippocampal pyramidal neurons and cerebellar Purkinje cells. Helps organize/anchor GABA_A receptor clusters in postsynaptic membrane. Loss disrupts GABAergic neurotransmission: impaired GABA_A receptor clustering, reduced tonic inhibitory currents, deficits in synaptic inhibition, culminating in myoclonic jerks and dystonia-like movements resembling myoclonus-dystonia syndrome. Links epsilon-sarcoglycan's molecular role to inhibitory neural circuit function. May influence calcium homeostasis and signaling in neurons. Also present in retina at inner/outer limiting membranes with Müller glial cell endfeet, potentially contributing to glial polarity, adhesion, or blood-retina barrier. Enriched in brain microvasculature, possibly supporting neurovascular unit and blood-brain barrier integrity. Mutations cause myoclonus-dystonia syndrome (NOT limb-girdle muscular dystrophy like other sarcoglycans) - hyperkinetic movements and dystonia from imbalance in neurotransmission (deficit in inhibitory signaling). No skeletal muscle disease because abundant α-sarcoglycan compensates, whereas smooth muscle and CNS rely on epsilon-sarcoglycan as primary isoform.